Welcome to our dedicated page for Axon Enterprise SEC filings (Ticker: AXON), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings for Axon Enterprise, Inc. (NASDAQ: AXON), a public safety technology company that reports under the Exchange Act. Through these filings, investors can review how Axon describes its Connected Devices and Software & Services segments, its public safety operating system strategy and its capital structure.
Axon uses periodic and current reports, including Forms 10-K, 10-Q and 8-K, to disclose financial performance, segment results, annual recurring revenue metrics and material events. Recent Form 8-K filings referenced in company communications include shareholder letters detailing quarterly revenue growth, updates to revenue outlook, and additional information on the performance of Software & Services and Connected Devices. Other 8-K filings describe governance changes, such as the appointment of new directors, and capital markets activity, including privately negotiated exchanges of 0.50% convertible senior notes due 2027 for cash and common stock, and a notice of redemption for these notes with terms for redemption and conversion.
On Stock Titan, Axon’s SEC filings are updated in near real time as documents are posted to the EDGAR system. AI-powered summaries help explain lengthy filings by highlighting key topics such as segment performance, annual recurring revenue, future contracted bookings, note exchanges and redemptions, and other material disclosures. Users can also review insider and executive-related filings, such as Forms 3, 4 and 5, to track equity awards, stock transactions and governance developments.
Whether you are analyzing Axon’s financial condition, understanding its use of convertible notes, or reviewing disclosures about acquisitions and emergency communications strategy, this filings page offers a centralized view of AXON’s regulatory history with AI tools that surface the most important information from each document.
Axon Enterprise reported strong Q1 2026 results, with revenue of $807 million, up 34% year over year, and record demand across TASER devices, cameras, software and counter-drone products. Net income rose to $169 million, a 21% margin, while Adjusted EBITDA reached $202 million, a 25% margin.
Software & Services revenue grew 35% to $355 million and Connected Devices rose 33% to $453 million. Annual recurring revenue climbed 35% to $1.5 billion and net revenue retention was 125%, reflecting expansion with existing customers.
Management raised full-year 2026 revenue growth guidance to 30%–32% and reiterated an Adjusted EBITDA margin target of 25.5%. The quarter included significant investment in AI-powered products and Dedrone, contributing to a free cash outflow of $55 million but supporting long-term growth initiatives.
Axon Enterprise Inc ownership filing shows Vanguard Capital Management beneficially owns 5,820,099 shares of Common Stock, representing 7.23% of the class as reported with an ownership date of 03/31/2026. The filer reports sole voting power for 776,974 shares and sole dispositive power for 5,820,099 shares. The disclosure states the position includes securities held for Vanguard funds and managed accounts and lists affiliated Vanguard entities that exercise dispositive or voting power on those holdings.
Axon Enterprise, Inc. is asking shareholders to vote at its fully virtual 2026 annual meeting on May 28, 2026, on three items: electing directors, an advisory vote on executive pay, and ratifying PricewaterhouseCoopers as auditor for 2026.
The proxy highlights Axon’s strategy as an AI‑driven, integrated hardware and software platform spanning TASER devices, cameras, cloud evidence, real‑time operations and 911 solutions. For 2025, Axon reports record revenue of $2.8 billion, up 33%, its fourth straight year above 30% growth, with Software & Services now 43% of revenue, annual recurring revenue of $1.3 billion, and net revenue retention of 125%.
Net income was $125 million (4.5% margin) and adjusted EBITDA was $710 million (25.5% margin), while bookings reached $7.4 billion, up 46%. The board stresses independent leadership, majority voting for directors, proxy access, refreshed tenure and term limits, and expanded oversight of ESG, cybersecurity and AI.
Axon Enterprise, Inc. reports that director Matthew McBrady has informed the Board that he will not stand for re-election at the Company’s 2026 Annual Meeting of Shareholders. He will continue serving as a director until his term expires at the meeting.
The Company states that Mr. McBrady’s decision is not due to any disagreement with Axon regarding its operations, policies, or practices. The Board expresses appreciation for his commitment, leadership, and contributions to the Company’s growth during his years of service.
Axon Enterprise CHIEF REVENUE OFFICER Cameron Brooks reported a routine share withholding tied to equity compensation. On the transaction date, 5,849.7 shares of Common Stock were disposed of to cover tax obligations from the vesting of restricted stock units.
These shares were withheld rather than sold in the open market, reflecting a tax-withholding disposition under the company’s 2024 eXponential Stock Plan. After this event, Brooks directly held 51,695.69 shares of Axon common stock, as reported in the filing.
Axon Enterprise Inc — The Vanguard Group filed Amendment No. 12 to a Schedule 13G/A reporting beneficial ownership of 0 shares (0%) of Axon common stock. The filing explains that, in accordance with SEC Release No. 34-39538 (January 12, 1998), certain Vanguard subsidiaries and business divisions will report beneficial ownership separately following an internal realignment on January 12, 2026. The amendment is signed by Ashley Grim, Head of Global Fund Administration, dated 03/26/2026.
Axon Enterprise director Jeri Williams reported an open-market sale of common stock. On March 17, 2026, Williams sold 157 shares at a price of $490.00 per share. After the sale, Williams directly owned 1,159 shares of Axon common stock. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan adopted on December 8, 2025, indicating it was scheduled in advance rather than timed discretionarily.
Axon Enterprise director Erika Nardini sold shares in an open-market trade. On March 17, 2026, she sold 198 shares of common stock at an average price of $506.579 per share. After this transaction, she directly holds 1,946 Axon common shares.